Digbi Expands Its Employer Platform Into Menopause and HRT Care

Digbi Health is expanding its employer healthcare platform into menopause and hormone replacement therapy care, another example of specialty benefits being consolidated onto broader employer health platforms rather than purchased as standalone point solutions.

The company announced October 2 that its Precision Biology platform now includes clinical HRT care alongside obesity, metabolic, gastrointestinal and inflammatory care.

According to Digbi, more than 300 employers and health plans that already contract with the company can make the new service available under their existing agreements, and multiple clients are incorporating it into their 2027 plan designs.

The bigger story is consolidation

Employer health benefits have become increasingly fragmented.

An employer might separately contract for obesity management, GLP-1 support, gastrointestinal care, menopause care, behavioral health and other specialty programs.

Each additional vendor can create another contract, eligibility feed, member experience, implementation process and fee structure.

Digbi is taking the opposite approach.

Its strategy is to put multiple conditions onto a single clinical and technology platform.

The company says 60% of its clients have already consolidated previously separate obesity, metabolic and gastrointestinal programs onto Digbi.

Adding menopause and HRT extends that model into another rapidly growing employer-benefit category.

What employers are getting

The expanded offering brings HRT into the same care environment Digbi uses for metabolic and inflammatory conditions.

Members can access GLP-1 and HRT prescribing through one clinical team, while Digbi uses genetic, gut microbiome, blood-biomarker and other health data to personalize its broader lifestyle and clinical programs.

For employers, the operational pitch is straightforward: add menopause care without procuring and implementing another independent point solution.

Digbi specifically says its existing employer and health-plan customers can offer the service under their current agreements.

That matters because contracting friction can be one of the barriers to expanding specialty benefits.

Existing employer relationships create distribution

Digbi says its platform is accessible to approximately 30 million individuals through more than 300 employers and health plans.

That installed base gives a new specialty service immediate potential distribution.

Rather than winning hundreds of new employer contracts specifically for menopause care, Digbi can attempt to expand the scope of relationships it already has.

The company also says many clients are already incorporating the new capabilities into 2027 plan designs.

It has not publicly identified those employers in this announcement, so DirectContract is not treating that statement as evidence that every existing client has adopted the HRT benefit.

The savings claims need context

Digbi cited financial results from its broader platform in announcing the expansion.

The company says clients consolidating two or more programs generated per-member savings two to three times greater than independently contracted point solutions.

It also cites a peer-reviewed actuarial claims analysis across seven self-insured employers that documented a $3,012 reduction in total healthcare expenditures per member per year.

Those findings relate to Digbi's broader precision-biology care model. They should not be interpreted as demonstrated savings from the newly launched menopause/HRT component.

No HRT-specific employer savings results were disclosed in the October 2 announcement.

That distinction will matter as employers evaluate whether consolidating specialty programs actually produces better economics than contracting with category-specific vendors.

Why this matters for direct employer healthcare

The employer healthcare market is moving through two changes at the same time.

First, employers are carving more clinical categories away from the traditional one-network-fits-all model.

Second, they are confronting the complexity created by having too many carve-outs.

That creates an opening for platforms capable of aggregating specialty services under a single employer contract.

Included Health's recent move toward an integrated health-plan architecture is one example.

Digbi's expansion represents another version of the same trend at the specialty-care layer.

The question is increasingly not just whether employers will use specialty carve-outs.

It is how many vendors they will need to manage them.

What to watch next

DirectContract will be watching for:

• named employers adopting Digbi's menopause/HRT benefit;
• the number of 2027 employer implementations;
• HRT-specific utilization and outcomes;
• whether employers replace standalone menopause vendors;
• incremental versus bundled pricing;
• HRT-specific claims savings; and
• additional specialty categories being consolidated onto broader employer platforms.

For now, the meaningful development is distribution: Digbi has turned a new specialty benefit into an extension available across an existing base of more than 300 employer and health-plan relationships.

Track employer specialty carve-outs and alternative purchasing arrangements in the Direct Contract Deal Tracker.

Sources

• Digbi Health — October 2, 2026 platform expansion announcement
• Digbi Health